Connection
Nicholas Foreman to Drug Approval
This is a "connection" page, showing publications Nicholas Foreman has written about Drug Approval.
|
|
Connection Strength |
|
 |
|
 |
|
0.149 |
|
|
|
-
Donson AM, Amani V, Warner EA, Griesinger AM, Witt DA, Levy JMM, Hoffman LM, Hankinson TC, Handler MH, Vibhakar R, Dorris K, Foreman NK. Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma. Mol Cancer Ther. 2018 09; 17(9):1984-1994.
Score: 0.149